Header Logo

Connection

BENJAMIN DENEEN to Humans

Back to Details
This is a "connection" page, showing publications BENJAMIN DENEEN has written about Humans.
BENJAMIN DENEEN
Connection Strength
0.341
Humans
  1. Comparative Transcriptomic Analysis of Cerebellar Astrocytes across Developmental Stages and Brain Regions. Int J Mol Sci. 2024 Jan 13; 25(2).
    View in: PubMed
    Score: 0.019
  2. Remote neuronal activity drives glioma progression through SEMA4F. Nature. 2023 Jul; 619(7971):844-850.
    View in: PubMed
    Score: 0.018
  3. Glioma epileptiform activity and progression are driven by IGSF3-mediated potassium dysregulation. Neuron. 2023 03 01; 111(5):682-695.e9.
    View in: PubMed
    Score: 0.018
  4. Sculpting Astrocyte Diversity through Circuits and Transcription. Neuroscientist. 2023 08; 29(4):445-460.
    View in: PubMed
    Score: 0.017
  5. Identification of diverse tumor endothelial cell populations in malignant glioma. Neuro Oncol. 2021 06 01; 23(6):932-944.
    View in: PubMed
    Score: 0.016
  6. Astrocytogenesis: where, when, and how. F1000Res. 2020; 9.
    View in: PubMed
    Score: 0.015
  7. Nuclear factor I-A regulates diverse reactive astrocyte responses after CNS injury. J Clin Invest. 2019 10 01; 129(10):4408-4418.
    View in: PubMed
    Score: 0.014
  8. A glial blueprint for gliomagenesis. Nat Rev Neurosci. 2018 07; 19(7):393-403.
    View in: PubMed
    Score: 0.013
  9. Daam2 driven degradation of VHL promotes gliomagenesis. Elife. 2017 10 20; 6.
    View in: PubMed
    Score: 0.012
  10. Identification of diverse astrocyte populations and their malignant analogs. Nat Neurosci. 2017 Mar; 20(3):396-405.
    View in: PubMed
    Score: 0.012
  11. Temporal Profiling of Astrocyte Precursors Reveals Parallel Roles for Asef during Development and after Injury. J Neurosci. 2016 11 23; 36(47):11904-11917.
    View in: PubMed
    Score: 0.011
  12. Astrocyte development: A Guide for the Perplexed. Glia. 2015 Aug; 63(8):1320-9.
    View in: PubMed
    Score: 0.010
  13. Apcdd1 stimulates oligodendrocyte differentiation after white matter injury. Glia. 2015 Oct; 63(10):1840-9.
    View in: PubMed
    Score: 0.010
  14. Glial development: the crossroads of regeneration and repair in the CNS. Neuron. 2014 Jul 16; 83(2):283-308.
    View in: PubMed
    Score: 0.010
  15. Astrocyte form and function in the developing central nervous system. Semin Pediatr Neurol. 2013 Dec; 20(4):230-5.
    View in: PubMed
    Score: 0.009
  16. Astrocytes: the missing link in neurologic disease? Semin Pediatr Neurol. 2013 Dec; 20(4):236-41.
    View in: PubMed
    Score: 0.009
  17. The miR-223/nuclear factor I-A axis regulates glial precursor proliferation and tumorigenesis in the CNS. J Neurosci. 2013 Aug 14; 33(33):13560-8.
    View in: PubMed
    Score: 0.009
  18. Developmental origins of astrocyte heterogeneity: the final frontier of CNS development. Dev Neurosci. 2012; 34(5):379-88.
    View in: PubMed
    Score: 0.009
  19. Evidence that nuclear factor IA inhibits repair after white matter injury. Ann Neurol. 2012 Aug; 72(2):224-33.
    View in: PubMed
    Score: 0.008
  20. Sox9 and NFIA coordinate a transcriptional regulatory cascade during the initiation of gliogenesis. Neuron. 2012 Apr 12; 74(1):79-94.
    View in: PubMed
    Score: 0.008
  21. Daam2 is required for dorsal patterning via modulation of canonical Wnt signaling in the developing spinal cord. Dev Cell. 2012 Jan 17; 22(1):183-96.
    View in: PubMed
    Score: 0.008
  22. Next Directions in the Neuroscience of Cancers Arising outside the CNS. Cancer Discov. 2024 Apr 04; 14(4):669-673.
    View in: PubMed
    Score: 0.005
  23. The immune system and metabolic products in epilepsy and glioma-associated epilepsy: emerging therapeutic directions. JCI Insight. 2024 Jan 09; 9(1).
    View in: PubMed
    Score: 0.005
  24. Understanding the microenvironment and how this controls cell fate. Dev Cell. 2023 Dec 18; 58(24):2819-2821.
    View in: PubMed
    Score: 0.005
  25. Functional analysis of the EWS/ETS target gene uridine phosphorylase. Cancer Res. 2003 Jul 15; 63(14):4268-74.
    View in: PubMed
    Score: 0.005
  26. PIM3 proto-oncogene kinase is a common transcriptional target of divergent EWS/ETS oncoproteins. Mol Cell Biol. 2003 Jun; 23(11):3897-908.
    View in: PubMed
    Score: 0.005
  27. The genomic landscape of familial glioma. Sci Adv. 2023 04 28; 9(17):eade2675.
    View in: PubMed
    Score: 0.004
  28. Cancer neuroscience: State of the field, emerging directions. Cell. 2023 04 13; 186(8):1689-1707.
    View in: PubMed
    Score: 0.004
  29. CXCR4 expression is associated with proneural-to-mesenchymal transition in glioblastoma. Int J Cancer. 2023 02 15; 152(4):713-724.
    View in: PubMed
    Score: 0.004
  30. Assessing Gq-GPCR-induced human astrocyte reactivity using bioengineered neural organoids. J Cell Biol. 2022 02 09; 221(4).
    View in: PubMed
    Score: 0.004
  31. Human Astrocytes Exhibit Tumor Microenvironment-, Age-, and Sex-Related Transcriptomic Signatures. J Neurosci. 2022 02 23; 42(8):1587-1603.
    View in: PubMed
    Score: 0.004
  32. CX3CR1 and malignant progression of glioma. Aging (Albany NY). 2021 09 12; 13(17):20856-20857.
    View in: PubMed
    Score: 0.004
  33. Reactive astrocyte nomenclature, definitions, and future directions. Nat Neurosci. 2021 03; 24(3):312-325.
    View in: PubMed
    Score: 0.004
  34. Systematic analysis of purified astrocytes after SCI unveils Zeb2os function during astrogliosis. Cell Rep. 2021 02 02; 34(5):108721.
    View in: PubMed
    Score: 0.004
  35. Roadmap for the Emerging Field of Cancer Neuroscience. Cell. 2020 04 16; 181(2):219-222.
    View in: PubMed
    Score: 0.004
  36. BRCA1/BRCA2-containing complex subunit 3 controls oligodendrocyte differentiation by dynamically regulating lysine 63-linked ubiquitination. Glia. 2019 09; 67(9):1775-1792.
    View in: PubMed
    Score: 0.003
  37. Brain Region-Specific Gene Signatures Revealed by Distinct Astrocyte Subpopulations Unveil Links to Glioma and Neurodegenerative Diseases. eNeuro. 2019 Mar-Apr; 6(2).
    View in: PubMed
    Score: 0.003
  38. Pancreatic Cell Fate Determination Relies on Notch Ligand Trafficking by NFIA. Cell Rep. 2018 12 26; 25(13):3811-3827.e7.
    View in: PubMed
    Score: 0.003
  39. Atrx inactivation drives disease-defining phenotypes in glioma cells of origin through global epigenomic remodeling. Nat Commun. 2018 03 13; 9(1):1057.
    View in: PubMed
    Score: 0.003
  40. Pan-Cancer Molecular Classes Transcending Tumor Lineage Across 32 Cancer Types, Multiple Data Platforms, and over 10,000 Cases. Clin Cancer Res. 2018 05 01; 24(9):2182-2193.
    View in: PubMed
    Score: 0.003
  41. TEM8/ANTXR1-Specific CAR T Cells as a Targeted Therapy for Triple-Negative Breast Cancer. Cancer Res. 2018 01 15; 78(2):489-500.
    View in: PubMed
    Score: 0.003
  42. A novel tumor-promoting role for nuclear factor IA in glioblastomas is mediated through negative regulation of p53, p21, and PAI1. Neuro Oncol. 2014 Jan; 16(2):191-203.
    View in: PubMed
    Score: 0.002
  43. Astrocytes and disease: a neurodevelopmental perspective. Genes Dev. 2012 May 01; 26(9):891-907.
    View in: PubMed
    Score: 0.002
  44. Nuclear factor IA is expressed in astrocytomas and is associated with improved survival. Neuro Oncol. 2010 Feb; 12(2):122-32.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.